Literature DB >> 22302242

Myosin light chain kinase is involved in the mechanism of gastrointestinal dysfunction in diabetic rats.

Wenchao Hu1, Ping Feng.   

Abstract

BACKGROUND: It is well established that smooth muscle contractility is regulated by an elevation of cytosolic Ca(2+) via myosin light chain phosphorylation, which is activated by myosin light chain kinase (MLCK). Recently, MLCK has been demonstrated to play an important role in smooth muscle contraction and normal gastrointestinal motility. AIMS: The aim of our study is to investigate whether MLCK is involved in the mechanism of gastrointestinal dysfunction and the ameliorating effects of insulin on gastrointestinal dysfunction in diabetic rats.
METHODS: A diabetic rat model was established by an intravenous injection with streptozotocin. Rats were randomized into three groups: control group, diabetic group, and insulin-treated group. The gastrointestinal functions were assessed in terms of gastric emptying and intestinal transit. The expression of MLCK in the pylorus and ileum of the three groups was determined by real-time polymerase chain reaction (PCR) and Western blot methods.
RESULTS: The diabetic group exhibited a significant delay in gastric emptying and intestinal transit than the control group. Insulin treatment significantly ameliorated the gastric emptying and intestinal transit in diabetic rats. The expression levels of MLCK in the pylorus and ileum of the diabetic group were both significantly decreased compared with the control group, and the changes of MLCK expression in these tissues of diabetic rats were partially reversed after treatment with insulin.
CONCLUSIONS: Decreased expression of MLCK in gastrointestinal tissues could be a possible cause for gastrointestinal dysfunction. Insulin may partly ameliorate gastrointestinal dysfunction by restoring the expression of MLCK.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22302242     DOI: 10.1007/s10620-012-2041-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

Review 1.  Interstitial cells of Cajal: primary targets of enteric motor innervation.

Authors:  S M Ward; K M Sanders
Journal:  Anat Rec       Date:  2001-01-01

Review 2.  Ghrelin in gastrointestinal diseases and disorders: a possible role in the pathophysiology and clinical implications (review).

Authors:  Magdy El-Salhy
Journal:  Int J Mol Med       Date:  2009-12       Impact factor: 4.101

3.  Effects of systemic inhibition of Rho kinase on blood pressure and renal haemodynamics in diabetic rats.

Authors:  R Komers; T T Oyama; D R Beard; S Anderson
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

4.  Myosin light-chain phosphorylation in diabetic cardiomyopathy in rats.

Authors:  X Liu; N Takeda; N S Dhalla
Journal:  Metabolism       Date:  1997-01       Impact factor: 8.694

Review 5.  Smooth muscle signalling pathways in health and disease.

Authors:  H R Kim; S Appel; S Vetterkind; S S Gangopadhyay; K G Morgan
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310

Review 6.  Diabetes mellitus and gastric emptying: questions and issues in clinical practice.

Authors:  Melvin Samsom; Adil Bharucha; John E Gerich; Kathrin Herrmann; Jörg Limmer; Rainer Linke; David Maggs; Jörg Schirra; Adrian Vella; Hans-Jürgen Wörle; Burkhard Göke
Journal:  Diabetes Metab Res Rev       Date:  2009-09       Impact factor: 4.876

7.  Involvement of cyclooxygenase 2 and prostagladin E(2) in the effects of insulin on gastric emptying in male rats.

Authors:  W -J Huang; C -R Hung; M -C Chen; J -R Wang; M -L Doong; C -K Wang; C -T Hung; P S Wang
Journal:  J Physiol Pharmacol       Date:  2009-09       Impact factor: 3.011

8.  Impairment of α1-adrenoceptor-mediated contractile activity in caudal arterial smooth muscle from type 2 diabetic Goto-Kakizaki rats.

Authors:  Mitsuo Mita; Takuto Kuramoto; Kazushi Ito; Natsuko Toguchi-Senrui; Shigeru Hishinuma; Michael P Walsh; Masaru Shoji
Journal:  Clin Exp Pharmacol Physiol       Date:  2009-09-28       Impact factor: 2.557

9.  Immediate insulin treatment prevents gut motility alterations and loss of nitrergic neurons in the ileum and colon of rats with streptozotocin-induced diabetes.

Authors:  Ferenc Izbéki; Tibor Wittman; András Rosztóczy; Nikolett Linke; Nikolett Bódi; Eva Fekete; Mária Bagyánszki
Journal:  Diabetes Res Clin Pract       Date:  2008-02-01       Impact factor: 5.602

10.  Effect of insulin on small intestinal transit in normal mice is independent of blood glucose level.

Authors:  Peddyreddy Murali Krishna Reddy; Steven Aibor Dkhar; Ramaswamy Subramanian
Journal:  BMC Pharmacol       Date:  2006-02-01
View more
  8 in total

1.  Proteomics and Phosphoproteomics of Circulating Extracellular Vesicles Provide New Insights into Diabetes Pathobiology.

Authors:  Yury O Nunez Lopez; Anton Iliuk; Alejandra M Petrilli; Carley Glass; Anna Casu; Richard E Pratley
Journal:  Int J Mol Sci       Date:  2022-05-21       Impact factor: 6.208

Review 2.  Diabetic gastrointestinal motility disorders and the role of enteric nervous system: current status and future directions.

Authors:  S S Yarandi; S Srinivasan
Journal:  Neurogastroenterol Motil       Date:  2014-03-24       Impact factor: 3.598

3.  Changes of phasic and tonic smooth muscle function of jejunum in type 2 diabetic Goto-Kakizaki rats.

Authors:  Jing-Bo Zhao; Peng-Min Chen; Hans Gregersen
Journal:  World J Diabetes       Date:  2013-12-15

4.  Myosin Va but Not nNOSα is Significantly Reduced in Jejunal Musculomotor Nerve Terminals in Diabetes Mellitus.

Authors:  Arun Chaudhury; Marcilio Hubner De Miranda-Neto; Renata Virginia Fernandes Pereira; Jacqueline Nelisis Zanoni
Journal:  Front Med (Lausanne)       Date:  2014-06-20

5.  Olanzapine May Inhibit Colonic Motility Associated with the 5-HT Receptor and Myosin Light Chain Kinase.

Authors:  Jiarui Zhang; Ying Qiao; Jingjing Le; Daliang Sun; Yangtai Guan; Zezhi Li
Journal:  Psychiatry Investig       Date:  2016-03-23       Impact factor: 2.505

6.  The Altered Signaling on EFS-Induced Colon Contractility in Diabetic Rats.

Authors:  Wynn Thein; Wah Wah Po; Dong Min Kim; Uy Dong Sohn
Journal:  Biomol Ther (Seoul)       Date:  2020-07-01       Impact factor: 4.634

7.  Critical role for the lung endothelial nonmuscle myosin light-chain kinase isoform in the severity of inflammatory murine lung injury.

Authors:  Carrie L Kempf; Saad Sammani; Tadeo Bermudez; Jin H Song; Vivian Reyes Hernon; Matthew K Hufford; Jessica Burt; Sara M Camp; Steven M Dudek; Joe G N Garcia
Journal:  Pulm Circ       Date:  2022-04-07       Impact factor: 2.886

8.  MYLK and MYL9 expression in non-small cell lung cancer identified by bioinformatics analysis of public expression data.

Authors:  Xiang Tan; Mingwu Chen
Journal:  Tumour Biol       Date:  2014-09-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.